| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.39 | 0.03 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.39 | 0.03 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.065 | 0.03 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.03 |